293 related articles for article (PubMed ID: 28881139)
1. Fracture-Targeted Delivery of β-Catenin Agonists via Peptide-Functionalized Nanoparticles Augments Fracture Healing.
Wang Y; Newman MR; Ackun-Farmmer M; Baranello MP; Sheu TJ; Puzas JE; Benoit DSW
ACS Nano; 2017 Sep; 11(9):9445-9458. PubMed ID: 28881139
[TBL] [Abstract][Full Text] [Related]
2. Advancing Bone-Targeted Drug Delivery: Leveraging Biological Factors and Nanoparticle Designs to Improve Therapeutic Efficacy.
Xiao B; Ackun-Farmmer MA; Adjei-Sowah E; Liu Y; Chandrasiri I; Benoit DSW
ACS Biomater Sci Eng; 2024 Apr; 10(4):2224-2234. PubMed ID: 38537162
[TBL] [Abstract][Full Text] [Related]
3. Bone-Targeted Nanoparticle Drug Delivery System-Mediated Macrophage Modulation for Enhanced Fracture Healing.
Xiao B; Liu Y; Chandrasiri I; Adjei-Sowah E; Mereness J; Yan M; Benoit DSW
Small; 2024 Feb; 20(7):e2305336. PubMed ID: 37797180
[TBL] [Abstract][Full Text] [Related]
4. Exogenous activation of Wnt/β-catenin signaling attenuates binge alcohol-induced deficient bone fracture healing.
Lauing KL; Sundaramurthy S; Nauer RK; Callaci JJ
Alcohol Alcohol; 2014; 49(4):399-408. PubMed ID: 24627571
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of GSK-3β rescues the impairments in bone formation and mechanical properties associated with fracture healing in osteoblast selective connexin 43 deficient mice.
Loiselle AE; Lloyd SA; Paul EM; Lewis GS; Donahue HJ
PLoS One; 2013; 8(11):e81399. PubMed ID: 24260576
[TBL] [Abstract][Full Text] [Related]
6. Controlled and sustained delivery of siRNA/NPs from hydrogels expedites bone fracture healing.
Wang Y; Malcolm DW; Benoit DSW
Biomaterials; 2017 Sep; 139():127-138. PubMed ID: 28601703
[TBL] [Abstract][Full Text] [Related]
7. Dietary phlorizin enhances osteoblastogenic bone formation through enhancing β-catenin activity via GSK-3β inhibition in a model of senile osteoporosis.
Antika LD; Lee EJ; Kim YH; Kang MK; Park SH; Kim DY; Oh H; Choi YJ; Kang YH
J Nutr Biochem; 2017 Nov; 49():42-52. PubMed ID: 28866105
[TBL] [Abstract][Full Text] [Related]
8. Titanium particle-induced osteogenic inhibition and bone destruction are mediated by the GSK-3β/β-catenin signal pathway.
Gu Y; Wang Z; Shi J; Wang L; Hou Z; Guo X; Tao Y; Wu X; Zhou W; Liu Y; Zhang W; Xu Y; Yang H; Xue F; Geng D
Cell Death Dis; 2017 Jun; 8(6):e2878. PubMed ID: 28617442
[TBL] [Abstract][Full Text] [Related]
9. Poly aspartic acid peptide-linked PLGA based nanoscale particles: potential for bone-targeting drug delivery applications.
Jiang T; Yu X; Carbone EJ; Nelson C; Kan HM; Lo KW
Int J Pharm; 2014 Nov; 475(1-2):547-57. PubMed ID: 25194353
[TBL] [Abstract][Full Text] [Related]
10. Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo.
Kulkarni NH; Onyia JE; Zeng Q; Tian X; Liu M; Halladay DL; Frolik CA; Engler T; Wei T; Kriauciunas A; Martin TJ; Sato M; Bryant HU; Ma YL
J Bone Miner Res; 2006 Jun; 21(6):910-20. PubMed ID: 16753022
[TBL] [Abstract][Full Text] [Related]
11. Silencing long non-coding RNA MEG3 accelerates tibia fraction healing by regulating the Wnt/β-catenin signalling pathway.
Liu YB; Lin LP; Zou R; Zhao QH; Lin FQ
J Cell Mol Med; 2019 Jun; 23(6):3855-3866. PubMed ID: 30955246
[TBL] [Abstract][Full Text] [Related]
12. Unleashing β-catenin with a new anti-Alzheimer drug for bone tissue regeneration.
Comeau-Gauthier M; Tarchala M; Luna JLR; Harvey E; Merle G
Injury; 2020 Nov; 51(11):2449-2459. PubMed ID: 32829895
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of beta-catenin signaling by Pb leads to incomplete fracture healing.
Beier EE; Sheu TJ; Buckley T; Yukata K; O'Keefe R; Zuscik MJ; Puzas JE
J Orthop Res; 2014 Nov; 32(11):1397-405. PubMed ID: 25044211
[TBL] [Abstract][Full Text] [Related]
14. Connexin 43 Modulates Osteogenic Differentiation of Bone Marrow Stromal Cells Through GSK-3beta/Beta-Catenin Signaling Pathways.
Lin FX; Zheng GZ; Chang B; Chen RC; Zhang QH; Xie P; Xie D; Yu GY; Hu QX; Liu DZ; Du SX; Li XD
Cell Physiol Biochem; 2018; 47(1):161-175. PubMed ID: 29763908
[TBL] [Abstract][Full Text] [Related]
15. Macrophage depletion increases target specificity of bone-targeted nanoparticles.
Ackun-Farmmer MA; Xiao B; Newman MR; Benoit DSW
J Biomed Mater Res A; 2022 Jan; 110(1):229-238. PubMed ID: 34319645
[TBL] [Abstract][Full Text] [Related]
16. Anti-DKK1 antibody promotes bone fracture healing through activation of β-catenin signaling.
Jin H; Wang B; Li J; Xie W; Mao Q; Li S; Dong F; Sun Y; Ke HZ; Babij P; Tong P; Chen D
Bone; 2015 Feb; 71():63-75. PubMed ID: 25263522
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of GSK-3β increases trabecular bone volume but not cortical bone volume in adenine-induced uremic mice with severe hyperparathyroidism.
Tatsumoto N; Arioka M; Yamada S; Takahashi-Yanaga F; Tokumoto M; Tsuruya K; Kitazono T; Sasaguri T
Physiol Rep; 2016 Nov; 4(21):. PubMed ID: 27803315
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3α/β inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineage.
Gambardella A; Nagaraju CK; O'Shea PJ; Mohanty ST; Kottam L; Pilling J; Sullivan M; Djerbi M; Koopmann W; Croucher PI; Bellantuono I
J Bone Miner Res; 2011 Apr; 26(4):811-21. PubMed ID: 20939016
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin.
Shimozaki S; Yamamoto N; Domoto T; Nishida H; Hayashi K; Kimura H; Takeuchi A; Miwa S; Igarashi K; Kato T; Aoki Y; Higuchi T; Hirose M; Hoffman RM; Minamoto T; Tsuchiya H
Oncotarget; 2016 Nov; 7(47):77038-77051. PubMed ID: 27780915
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
